Australia markets closed

Graybug Vision, Inc. (GRAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.6500-0.0800 (-2.14%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.7300
Open3.7400
Bid3.6000 x 900
Ask3.6900 x 800
Day's range3.5900 - 3.7500
52-week range3.4300 - 37.8800
Volume98,932
Avg. volume743,790
Market cap77.689M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.1500
Earnings date10 Nov 2021 - 15 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.75
  • GlobeNewswire

    Graybug Vision to Participate in the Cantor Virtual Global Healthcare Conference

    BALTIMORE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 11:20 a.m. ET / 8:20 a.m. PT. Dr. Guerard will provide a corporate update, in

  • GlobeNewswire

    Graybug Vision Announces Financial Results for the Three and Six Months Ended June 30, 2021, and Recent Corporate Developments

    REDWOOD CITY, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today provided an update on recent corporate developments and reported financial results for the three and six months ended June 30, 2021. Recent Corporate Developments Completed six-month extended observation period of ALTISSIMO Phase 2b trial in wet AMD—

  • GlobeNewswire

    Graybug Vision to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference

    REDWOOD CITY, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will participate in a panel discussion titled “Goldeneye” at the Wedbush PacGrow Healthcare Conference on Wednesday, August 11, 2021 at 9:45 a.m. ET / 6:45 a.m. PT. A liv